Global Patient Safety, Oncology TA Intern; PhD

Company Description

Abb Vie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas immunology, oncology, neuroscience, and eye care and products and services in our Allergan Aesthetics portfolio. For more information about Abb Vie, please visit us at  Follow @abbvie on X, Facebook, Instagram, You Tube, Linked In and Tik Tok.

Envision spending your summer working with energetic colleagues and inspirational leaders, all while gaining world‑class experience in one of the most dynamic organizations in the pharmaceutical industry. This is a reality for Abb Vie Interns.

The Global Patient Safety, Oncology Therapeutic Area (TA) Intern will spend your summer engaged with energetic colleagues and inspirational leaders, gaining world‑class experience within one of the most dynamic organizations in the pharmaceutical industry. The intern will support the enhancement of clinical safety insights by leveraging reverse translatability to improve non‑clinical capabilities (e.g., complex in vitro models (CIVM) or new approach methodologies (NAMs)).

Additionally, the intern will learn GPS processes and deliverables relevant to clinical development and patient safety.

The Global Patient Safety (GPS) organization works collaboratively and strategically with colleagues across the product lifecycle to identify, evaluate, understand, and communicate the safety profile of Abb Vie products to protect patients worldwide. The team plays a critical role in evaluating safety data relevant to Abb Vie for both pharmaceutical and medical device products.

The team is a high‑profile and high‑impact group of physicians and other health care professionals who work in close collaboration with a broad range of cross‑functional colleagues. The team works collaboratively to provide product data analysis, signal monitoring, and product insights so that together as a team, the Product Safety Team (PST) can implement appropriate actions to ensure patient safety.

As a member of the team, you are at the forefront of working with leaders to identify critical priorities and drive high‑value projects that make an impact on the safety of our patients.

• Collaborate with PST Leads and Preclinical Safety colleagues to identify gaps in current complex in vitro models (CIVM) and new approach methodologies (NAMs) capabilities as they relate to ongoing and potential clinical safety challenges.
• Partner with teams across Discovery, Development Biological Sciences, and Genomics, as well as external collaborators when appropriate, to enhance CIVM/NAMs and improve their utility in addressing clinical safety questions.
• Leverage reverse translatability to inform the development and refinement of non‑clinical models based on clinical safety insights.
• Assist in the effective utilization and organization of data related to model capabilities and enhancements.
• Contribute to the overall goals of bridging gaps between non‑clinical and clinical safety, helping to inform Abb Vie’s R&D pipeline and clinical safety decision‑making.
• Prepare summaries or presentations of findings and recommendations for internal stakeholders, demonstrating progress and impact on model capabilities.

• Currently enrolled in university, pursuing a PhD in biology, chemistry or related scientific discipline, or a programming or computational skill that is related to a scientific discipline, or other related degree.
• Must be enrolled in university for at least one semester following the internship.
• Experience with in vitro models (CIVM) and new approach methodologies (NAMs) capabilities.
• Ability to summarize complex information.
• Strong verbal and written communication skills.
• Takes initiative and always looks for improvement opportunities.

• Expected graduation date between December 2026 and June 2027.

• Competitive pay
• Relocation support for eligible students
• Opportunities for…